Cognition Therapeutics Ratios (2020-2026) | CGTX

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter)
36.26M58.92M55.75M53.18M51.99M48.04M44.81M41.37M36.97M37.01M36.61M30.97M28.91M26.87M21.56M31.51M45.89M42.27M
Equity Average (Quarter)
-75.77M-85.20M-17.72M50.01M46.32M41.61M39.78M38.02M35.08M31.66M26.70M26.67M25.93M18.75M16.62M15.51M9.65M21.78M35.40M32.09M
Invested Capital (Quarter)
-83.68M-86.72M51.27M48.74M43.90M39.32M40.25M35.78M34.39M28.93M24.47M28.86M23.01M14.48M18.75M12.27M7.03M36.53M34.27M29.91M
Leverage & Solvency
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)
-6.480.870.830.830.730.800.780.780.750.700.740.670.530.620.520.360.840.710.83
Valuation
Enterprise Value (Quarter)
-8.30M-54.72M-51.51M-45.77M-46.61M-41.56M-38.81M-37.19M-32.97M-29.92M-34.67M-28.53M-22.01M-25.01M-16.43M-10.74M-39.33M-36.81M-31.13M
Return Ratios
Return on Capital Employed (Quarter)
-64.43%-54.48%-66.05%-96.72%-84.20%-90.63%-115.77%-135.30%-189.28%-203.07%-228.55%-319.84%-303.79%-336.99%-575.61%-180.45%-149.52%-118.31%
Return on Assets (Quarter)
-0.01%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.02%-0.02%-0.02%-0.02%-0.02%-0.01%-0.01%-0.01%
Return on Equity (Quarter)
0.00%0.00%0.01%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.02%-0.02%-0.02%-0.03%-0.03%-0.03%-0.05%-0.02%-0.01%-0.01%